Larazotide Acetate Reduces Intestinal Permeability in a NASH Preclinical Study

Welcome to Celiac.com!

You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.
Celiac.com Sponsor (A1):

Celiac.com Sponsor (A1-M):
Get Celiac.com Updates:

Support Our Content

eNewsletter

Donate
By Jefferson Adams

December 20, 2018
By Jefferson Adams • December 20, 2018

Larazotide Acetate Reduces Intestinal Permeability in a NASH Preclinical Study

Followers 0
Reviewed and edited by a celiac disease expert.

Recent data show that larazotide acetate has a marked effect on intestinal permeability. Will that lead to new treatments?

Caption: Veiled. Image: CC--ButterflySha

Celiac.com 12/20/2018 - Intestinal permeability is thought to play a key role in the translocation of bacteria that lead to nonalcoholic fatty liver disease (NAFLD), a disorder in which fat accumulates in the liver. Intestinal permeability is also thought to play a significant role in the development of Nonalcoholic steatohepatitis (NASH).

In a new preclinical study, a team of researchers affiliated with Innovate Biopharmaceuticals recently assessed the effects of larazotide acetate on intestinal permeability. Their data from that study show that larazotide has a marked effect on intestinal permeability.

Celiac.com Sponsor (A12):
The company expects to see more data detailing the use of larazotide in combination with approved drugs liraglutide (VICTOZA®) and obeticholic acid (OCALIVA®), in development for treatment of NASH, by early 2019. Based on larazotide's ability to re-normalize intestinal permeability, the parent company plans to launch clinical development program targeted at NASH in 2019.

In the most recent study, researchers evaluated the effects of larazotide in a model of NASH that develops from consumption of a specified diet, the DIAMONDTM mouse model. The pre-clinical model confirms NAFLD/NASH in response to a high fat, high sugar Western diet, including insulin resistance, obesity, which mirrors human disease progression and histopathology.

As tested, larazotide triggered a clear reduction in gut barrier permeability, a known pathological abnormality in chronic liver diseases, specifically NASH. Any drug that can prevent or reduce gut permeability could be helpful in treating NASH. The company plans to share the complete NASH pre-clinical results for publication in 2019.

According to Dr. Arun Sanyal, Professor and Chair, Division of Gastroenterology, Hepatology and Nutrition at the Virginia Commonwealth University (VCU) School of Medicine, "Increased intestinal permeability has been linked to many aspects of metabolic syndrome including type 2 diabetes and nonalcoholic fatty liver disease. The demonstration of reduced gut permeability with larazotide in the setting of diet-induced obesity opens up the possibility of modulating the outcomes of metabolic syndrome, including NASH, via this mechanism and warrants further development for these indications."

Obviously, any drug that can reduce gut permeability could also have implications for the treatment of celiac disease. Look for celiac.com to bring you more news on efforts to develop treatments for NASH, NAFLD, and related conditions, as information becomes available.

Read more at: Nasdaq.com
celiac

celiac diease

disease

fatty liver

larazotide

liver

steatohepatitis
Share
https://www.celiac.com/celiac-disease/larazotide-acetate-reduces-intestinal-permeability-in-a-nash-preclinical-study-r4653/
Followers 0
Go to articles
User Feedback
- 2 Comments
Recommended Comments

Guest Carol T

Posted December 25, 2018

Share this comment

I have also a problem with vitamin and nutrient uptake. Will decreased permeability increase this?

Link to comment

Share on other sites

lyfan 12

Posted December 26, 2018

Share this comment

Carol, they are early in research and you can expect at least five years, more likely ten, before there's anything on the market. Since "uptake" can be more complex than just leaking across the intestine, you might want to contact the researchers to see if they have/can look into this aspect while the research is still early.

Link to comment

Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!
Register a new account

Sign in

Already have an account? Sign in here.
Sign In Now
Get Celiac.com Updates:

Support Celiac.com:

Join eNewsletter

Donate
About Me

Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

>VIEW ALL ARTICLES BY JEFFERSON ADAMS
Celiac.com Sponsor (A17):

Celiac.com Sponsor (A17):

Celiac.com Sponsors (A17-M):
Related Articles
Treatment for Intestinal Permeability by Roy Jamron
Celiac.com 07/01/2006 - With the likelihood that increased intestinal permeability in celiacs caused by gluten damage to the intestinal mucosa leads to a high prevalance of liver damage as well as an increase in food allergy and possible other medical conditions, emphasis on healing the intestinal mucosa should be given an elevated priority. Simply going on a gluten-free diet and waiting months or years for the intestine to heal may not be enough.
Friendly commensal gut bacteria are an important part of the intestinal barrier, and thus probiotics, such as yogurt, kefir, or supplemental
probiotic capsules, do help diminish the amount of endotoxins released by pathogenic gut bacteria getting through the barrier. Liver disease studies confirm the benefit of probiotics by reducing...

Read Full Article...

0 comments

14,918 views
Larazotide Acetate in Patients With Celiac Disease Undergoing a Gluten Challenge
Celiac.com 02/04/2013 - Ever wonder what happens to all those celiac disease patients who volunteer to do a gluten-challenge in the name of science? Well, the short answer is that they likely suffer, and may incur gut damage, at least in the short term.
A team of researchers looking for ways to reduce or eliminate that problem recently conducted a study using larazotide acetate, a first-in-class oral peptide that prevents tight junction opening, and may reduce gluten uptake and associated problems.
The research team included C. P. Kelly, P. H. R. Green, J. A. Murray, A. DiMarino, A. Colatrella, D. A. Leffler, T. Alexander, R. Arsenescu, F. Leon, J. G. Jiang, L. A. Arterburner, B. M. Paterson, R. N. and Fedorak. They are affiliated with the Celiac Center of Beth Israel Deaconess Medical...

Read Full Article...

2 comments

15,077 views
Higher Risk of Non-alcoholic Fatty Liver Disease After Celiac Diagnosis
Celiac.com 06/29/2015 - Non-alcoholic fatty liver disease is a common cause of chronic liver disease. There's good data showing that celiac disease changes intestinal permeability, and that treatment with a gluten-free diet often causes weight gain, but so far there is scant documentation of non-alcoholic fatty liver disease in patients with celiac disease.
A team of researchers recently set out to assess increased risk of non-alcoholic fatty liver disease following diagnosis of celiac disease. The research team include Norelle R. Reilly, Benjamin Lebwohl, Rolf Hultcrantz, Peter H.R. Green, and Jonas F. Ludvigsson. They are affiliated with the Department Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, and the Department of Pediatrics at Örebro University ...

Read Full Article...

1 comment

10,384 views
Celiac Patients on a Gluten-free Diet Face Increased Risk of Nonalcoholic Fatty Liver Disease
Celiac.com 10/24/2018 - Although some research has shown a connection between a gluten-free diet, altered macronutrient intake and metabolic syndrome, not much good data exists on the risk of nonalcoholic fatty liver disease in patients with celiac disease who follow a gluten-free diet. A team of researchers recently set out to assess the prevalence and relative risk of nonalcoholic fatty liver disease in celiac patients treated with a gluten-free diet.
The research team included F. Tovoli; G. Negrini; R. Farì; E. Guidetti; C. Faggiano; L. Napoli; L. Bolondi; and A. Granito of the Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
For many patients with metabolic syndrome, nonalcoholic fatty liver disease is common. To try to get some better i...

Read Full Article...

1 comment

7,101 views
Recent Activity
1. 3 hours ago - knitty kitty replied to CeliacChica's topic in Related Issues & Disorders
  30
  
  Muscle Twitching
  
  Hello, I'd have been here sooner, but I got tangled up in yarn... Restless leg syndrome (RLS) I've had. It's often associated with iron deficiency and B12 deficiency, but can also show up with any deficiencies in Vitamin C, copper, Vitamin D, and Thiamine, Pyridoxine, and magnesium. B12, Thiamine, and Pyridoxine will also help with peripheral neuropathy...
2. 7 hours ago - Jtestani posted a topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
  0
  
  Help with results please. As I have a appt after the New Year.
  
  My question is .. my test results Ttg (IgA 1.7 u/ml & IgG 3:3 u/ml) both negative & DGP IGG 7.1025 negative but DGP IGA postive at 36.2007 U/ML. Am I showing a negative test result? any insight helps as I have to wait till new year for next Doctor’s appt. Thanks
3. Saturday at 11:15 PM - StaciField replied to StaciField's topic in Related Issues & Disorders
  8
  
  My bone structure is disintegrating and I’m having to have my teeth removed
  
  There’s a Cosco in Auckland in New Zealand. It’s a bit away from where I live but it’s worth the travel for me. Very appreciative of your advice.
4. Saturday at 10:49 PM - Wheatwacked replied to More2Learn's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
  2
  
  Celiac Maybe a Possibility?
  
  It seems you have proven that you cannot eat gluten. You've done what your doctors have not been able to do in 40 years. That's your low vitamin D, a common symptom with Celiac Disease. Zinc is also a common defiency. Its an antiviral. that's why zinc gluconate lozenges work against airborne viruses. Vitamin D and the Immune System+ ...
5. Saturday at 08:47 PM - John.B posted a topic in Gluten-Free Foods, Products, Shopping & Medications
  0
  
  Allergy Meds
  
  Hello, Target recently changed their branding on the Up & Up Loratadine and no long have it labeled gluten free. I've not been able to find any meds labeled gluten free for allergies. Some lists showed them but the the packaging isn't labeled. Wondering if anyone knows of or has a list that would be safe for Celiac kiddos.